Price $1.39 |
Market Cap
18.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
8.48
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.7K
|
FCF
-
|
|
Op. Margin
-302.20%
|
Net Margin
-245.30%
|
ROE
-734.30%
|
ROI
-254.60%
|
|
ROA
-56.60%
|
EPS Growth
56.00%
|
Current Ratio
4.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 12.7M | Strong Buy |
| Medical Transcription Billing (MTBC) | $4.68 | - | - | 48.7M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $4.14 | - | - | 73.9M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $14.30 | - | - | 790.9M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $25.45 | - | - | 8.6B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
